Table 3.
Name of variables | Unstandardized coefficients | Exp B | 95% CI for Exp B | P value | ||
---|---|---|---|---|---|---|
B | SE | Lower | Upper | |||
Gender | ||||||
Male | Reference | |||||
Female | 0.42 | 0.16 | 1.52 | 1.11 | 2.08 | 0.009 |
Age | ||||||
≤ 40 years | Reference | |||||
41-60 years | 1.27 | 0.42 | 3.58 | 1.58 | 8.13 | 0.002 |
> 60 years | 2.29 | 0.43 | 9.92 | 4.28 | 23 | <0.0001 |
HbA1c (mg/dl) | ||||||
≤ 6.5 | Reference | |||||
6.51-7.5 | 0.13 | 0.22 | 1.14 | 0.72 | 1.80 | 0.57 |
≥ 7.51 | 0.54 | 0.23 | 1.72 | 1.12 | 2.64 | 0.013 |
HDL (mg/dl) | ||||||
≥ 61 | Reference | |||||
41-60 | 0.24 | 0.41 | 1.27 | 0.56 | 2.85 | 0.56 |
≤ 40 | 0.80 | 0.41 | 2.22 | 0.99 | 4.98 | 0.05 |
Duration of T2DM | ||||||
0-10 years | Reference | |||||
11-20 years | -0.12 | 0.19 | 0.88 | 0.61 | 1.27 | 0.50 |
> 20 years | 0.71 | 0.32 | 2.04 | 1.09 | 3.81 | 0.025 |
Education | ||||||
≥ 15 years | Reference | |||||
10-14 years | 1.43 | 0.31 | 4.21 | 2.29 | 7.72 | <0.0001 |
5-9 years | 3.83 | 0.30 | 46.12 | 25.47 | 83.51 | <0.0001 |
Nagelkerke R2 = .498, χ2value= 576.69, p < .0001. The odds of developing MCI in female T2DM patients was 1.52 times the odds of males. The odds of developing MCI in T2DM patients of age group 41-60 years was 3.58 times whereas the odds of developing MCI in T2DM patients of age group > 60 years was 9.92 times compared to <40 age group. The odds of developing MCI in T2DM patients with HbA1c levels > 7.51 levels was 1.72 times, duration of T2DM >20 years was 2.04 times and educational qualification of 5-9 years and 10-14 years were 46.12 times and 4.21 times respectively.